DNA repair: exploiting the Fanconi anemia pathway as a potential therapeutic target

Area of Science:

• Molecular Biology
• Genetics
• Oncology

Background:

• DNA damage is a constant cellular threat from internal and external factors, potentially leading to oncogenesis.
• Cells possess diverse DNA repair mechanisms, including the Fanconi anemia (FA) pathway, essential for homologous recombination.
• Mutations in FA genes cause Fanconi anemia, a disease linked to bone-marrow failure and cancer, with heterozygous mutations increasing cancer risk.

Purpose of the Study:

• To explore the functional interactions within the Fanconi anemia (FA) pathway.
• To investigate the concept of synthetic lethality in the context of FA pathway deficiencies.
• To identify novel therapeutic targets by understanding alternative DNA repair pathways cells rely on when the FA pathway is compromised.

Main Methods:

• Analysis of the Fanconi anemia (FA) protein interaction network.
• Investigating cellular responses to DNA damage in cells with varying FA pathway integrity.
• Exploring synthetic lethality by inhibiting alternative DNA repair pathways in FA-deficient cells.

Main Results:

• The Fanconi anemia (FA) pathway involves at least 15 interacting proteins critical for DNA repair.
• Cells deficient in the FA pathway exhibit dependency on alternative DNA repair mechanisms for survival.
• This dependency creates synthetic lethality, where inhibiting alternative pathways leads to cell death.

Conclusions:

• The Fanconi anemia (FA) pathway is a key player in DNA repair and genomic stability.
• Synthetic lethality strategies targeting alternative repair pathways in FA-deficient cancers offer a promising therapeutic avenue.
• Understanding FA pathway interactions can uncover new targets for cancer treatment.